Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Solomon

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Cutis|November 5, 2016
Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trialJames A Solomon, Stephen Tyring, Gerald Staedtler, et al.
Cutis|March 13, 2018
Perceptions of tanning risk among melanoma patients with a history of indoor tanningJennifer Nergard-Martin, Chauncey Caldwell, Morgan Barr, et al.
Cutis|November 23, 2016
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trialStephen Tyring, James A Solomon, Gerald Staedtler, et al.
Journal of the American Academy of Dermatology|November 14, 2025
Response to Schneeweiss et al, "Recognizing and avoiding pitfalls and bias in database research"John Meisenheimer, Robert P Dellavalle, James A Solomon, et al.
Journal of the American Academy of Dermatology|May 24, 2025
Letter from the editor: Behind the data: Pitfalls and bias in database researchJohn Meisenheimer, Robert P Dellavalle, James A Solomon, et al.
Journal of the American Academy of Dermatology|April 18, 2016
Gaps in the understanding and treatment of skin cancer in people of colorAjay Kailas, James A Solomon, Eliot N Mostow, et al.
Journal of the American Academy of Dermatology|March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Cutis|August 24, 2018
Acne treatment: analysis of acne-related social media posts and the impact on patient careBrittany Urso, Katelyn M Updyke, Renee Domozych, et al.
Orphanet Journal of Rare Diseases|September 2, 2016
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trialsAnne Lynn S Chang, Sarah T Arron, Michael R Migden, et al.
Journal of the American Academy of Dermatology|November 6, 2013
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegibAnne Lynn S Chang, James A Solomon, John D Hainsworth, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cutis|November 5, 2016
Investigator-reported efficacy of azelaic acid foam 15% in patients with papulopustular rosacea: secondary efficacy outcomes from a randomized, controlled, double-blind, phase 3 trialJames A Solomon, Stephen Tyring, Gerald Staedtler, et al.
Cutis|March 13, 2018
Perceptions of tanning risk among melanoma patients with a history of indoor tanningJennifer Nergard-Martin, Chauncey Caldwell, Morgan Barr, et al.
Cutis|November 23, 2016
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trialStephen Tyring, James A Solomon, Gerald Staedtler, et al.
Journal of the American Academy of Dermatology|November 14, 2025
Response to Schneeweiss et al, "Recognizing and avoiding pitfalls and bias in database research"John Meisenheimer, Robert P Dellavalle, James A Solomon, et al.
Journal of the American Academy of Dermatology|May 24, 2025
Letter from the editor: Behind the data: Pitfalls and bias in database researchJohn Meisenheimer, Robert P Dellavalle, James A Solomon, et al.
Journal of the American Academy of Dermatology|April 18, 2016
Gaps in the understanding and treatment of skin cancer in people of colorAjay Kailas, James A Solomon, Eliot N Mostow, et al.
Journal of the American Academy of Dermatology|March 18, 2018
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3Alexander Egeberg, Jashin J Wu, Neil Korman, et al.
Cutis|August 24, 2018
Acne treatment: analysis of acne-related social media posts and the impact on patient careBrittany Urso, Katelyn M Updyke, Renee Domozych, et al.
Orphanet Journal of Rare Diseases|September 2, 2016
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trialsAnne Lynn S Chang, Sarah T Arron, Michael R Migden, et al.
Journal of the American Academy of Dermatology|November 6, 2013
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegibAnne Lynn S Chang, James A Solomon, John D Hainsworth, et al.
Pageof 4